Literature DB >> 23722114

mTOR and lymphocyte metabolism.

Hu Zeng1, Hongbo Chi.   

Abstract

Upon antigen engagement and proper co-stimulation, naïve lymphocytes exit quiescence and undergo clonal expansion and differentiate into functional effector cells, after which they either die through apoptosis or survive as memory cells. Lymphocytes at different activation stages exhibit distinct metabolic signatures. Emerging evidence highlights a central role for the mechanistic target of rapamycin (mTOR) in bridging immune signals and metabolic cues to direct lymphocyte proliferation, differentiation and survival. Here we review recent advances in understanding the functional significance and signal transduction of mTOR in T cell biology, and the interplay between mTOR signaling and metabolic programs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722114      PMCID: PMC3759237          DOI: 10.1016/j.coi.2013.05.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  87 in total

1.  Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.

Authors:  Romana Tomasoni; Veronica Basso; Karolina Pilipow; Giovanni Sitia; Simona Saccani; Alessandra Agresti; Flore Mietton; Gioacchino Natoli; Sara Colombetti; Anna Mondino
Journal:  Eur J Immunol       Date:  2011-07       Impact factor: 5.532

2.  IL-7 enhances the survival and maintains the size of naive T cells.

Authors:  J C Rathmell; E A Farkash; W Gao; C B Thompson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 3.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

4.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

5.  Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells.

Authors:  Shin-ichiro Kagami; Takayoshi Owada; Hiroko Kanari; Yukari Saito; Akira Suto; Kei Ikeda; Koichi Hirose; Norihiko Watanabe; Itsuo Iwamoto; Hiroshi Nakajima
Journal:  Int Immunol       Date:  2009-04-20       Impact factor: 4.823

Review 6.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

7.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.

Authors:  Muhammet F Gulen; Zizhen Kang; Katarzyna Bulek; Wan Youzhong; Tae Whan Kim; Yi Chen; Cengiz Z Altuntas; Kristian Sass Bak-Jensen; Mandy J McGeachy; Jeong-Su Do; Hui Xiao; Greg M Delgoffe; Booki Min; Jonathan D Powell; Vincent K Tuohy; Daniel J Cua; Xiaoxia Li
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

9.  Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.

Authors:  Michael S Turner; Lawrence P Kane; Penelope A Morel
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

10.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

View more
  49 in total

1.  Tuning mTOR activity for immune balance.

Authors:  Kai Yang; Hongbo Chi
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

2.  The differential roles of mTOR, ERK, and JNK pathways in invariant natural killer T-cell function and survival.

Authors:  Jun Tian; Li Liu; Xiangai Wang; Xuewu Sun; Suli Mu; Chuanjun Wu; Maoqiang Han
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 3.  mTOR and metabolic regulation of conventional and regulatory T cells.

Authors:  Chaohong Liu; Nicole M Chapman; Peer W F Karmaus; Hu Zeng; Hongbo Chi
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

4.  The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes.

Authors:  Lomon So; Jongdae Lee; Miguel Palafox; Sharmila Mallya; Chaz G Woxland; Meztli Arguello; Morgan L Truitt; Nahum Sonenberg; Davide Ruggero; David A Fruman
Journal:  Sci Signal       Date:  2016-05-31       Impact factor: 8.192

Review 5.  New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.

Authors:  Mathias Lutz; Stephan Mielke
Journal:  Br J Clin Pharmacol       Date:  2016-06-22       Impact factor: 4.335

6.  Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma.

Authors:  Wasakorn Kittipongdaja; Xuesong Wu; Justine Garner; Xiping Liu; Steven M Komas; Sam T Hwang; Stefan M Schieke
Journal:  J Invest Dermatol       Date:  2015-04-21       Impact factor: 8.551

7.  Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation.

Authors:  Bo Pei; Meng Zhao; Brian C Miller; Jose Luis Véla; Monique W Bruinsma; Herbert W Virgin; Mitchell Kronenberg
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

8.  mTOR signaling and transcriptional regulation in T lymphocytes.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Transcription       Date:  2014

Review 9.  Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.

Authors:  Ying-Chun Lo; Chen-Fang Lee; Jonathan D Powell
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

10.  The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.

Authors:  Matjaz Vogelsang; Carlos N Martinez; Justin Rendleman; Anuj Bapodra; Karolina Malecek; Artur Romanchuk; Esther Kazlow; Richard L Shapiro; Russell S Berman; Michelle Krogsgaard; Iman Osman; Tomas Kirchhoff
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.